v3.21.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Cash Flows From Operating Activities    
Net loss $ (4,207) $ (6,494)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 1,532 1,319
Interest accretion expense 135 109
Bad debt (recovery) expense (140) 250
Mark to market on warrants 41 (26)
Stock-based compensation 259 418
Amortization of loan costs 52
Accrued interest 92
ESPP expense 27
Change in fair value of contingent consideration (57)
Other gains and expenses, net (3)
Other changes in operating assets and liabilities:    
Decrease in accounts receivable 317 289
Increase in other current assets (253) (1,125)
Decrease in accounts payable (1,534) (253)
Decrease in accrued salaries and bonus (988) (476)
Decrease in accrued liabilities (293) (1,149)
Increase in long-term liabilities 14 16
Net cash used in operating activities (5,006) (7,122)
Cash Flows From Investing Activity    
Sale of property and equipment 39
Net cash provided by investing activities 39
Cash Flows From Financing Activities    
Issuance of common stock, net of expenses 108 434
Issuance of Series B preferred stock, net of expenses 19,537
Loan proceeds 5,000
Loan expenses (74)
Payments on Line of Credit (1,800)
Net cash provided by financing activities 5,034 18,171
Net increase (decrease) in cash, cash equivalents and restricted cash 67 11,049
Cash, cash equivalents and restricted cash - beginning 3,372 2,321
Cash, cash equivalents and restricted cash - ending $ 3,439 $ 13,370

Source